Headlands Technologies’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$436K Buy
2025
Q1
$58.8K Buy
2024
Q4
Sell
2024
Q3
$669K Buy
2024
Q2
$252K Buy
2024
Q1
$27.7K Buy
2023
Q4
Sell
2023
Q3
$119K Buy
2023
Q2
$103K Buy
2023
Q1
$1.52K Buy